PharmaCyte Biotech Inc (PMCB)

[frosr6]

$PMCB WARNING BUYER BEWARE
Reverse Split (R/S)
As of July 27, 2017, the registrant had 973,167,811 outstanding shares of common stock.
Common stock, authorized 1,490,000,000 shares, $0.0001 par value,

A Reverse Split (R/S) is a stock split that reduces the number of outstanding shares and increases the per-share price proportionately. For example, if a company declares a one-for-ten Reverse Split (R/S), then a ten cent stock will be worth $1.00 after the Reverse Split (R/S), but the number of shares held by investors will be reduced by a ratio of one share for each ten shares they held prior to the split. If one held 10,000 shares prior to the Reverse Split (R/S), they will hold 1,000 shares after the Reverse Split (R/S). While there are legitimate reasons to do a Reverse Split (R/S), more often than not, when a penny stock company does a Reverse Split (R/S) to its stock, it is bad news for investors in the stock. Unless, a penny stock company has an outstanding future with growing revenues, additional shares will likely be issued in the months and years after the Reverse Split (R/S), and the stock will eventually trade down sharply over time.